drugset / Trial / NCT03402087

A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients

NCT03402087

Phase 1 Completed 30 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate effects of BMS-986165 on blood levels of methotrexate given as a single dose in healthy male patients.

Timeline

Start
2018-01-08
Primary completion
2018-03-20
Completion
2018-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule
Subject Methotrexate Small molecule
Background Leucovorin Small molecule